JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5851
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.26B
| $32.8K | ﹤0.01% |
2,454
-942
| -28% | -$12K |
2022 Q4
5 quarters
|
|
5852
Oramed Pharmaceuticals
ORMP
$189M
| $32.7K | ﹤0.01% |
11,210
-17,556
| -61% | -$49.1K |
2021 Q2
11 quarters
|
|
5853
Orchestra BioMed
OBIO
$362M
| $32.7K | ﹤0.01% |
6,196
-3,410
| -35% | -$23.1K |
2023 Q2
3 quarters
|
|
5854
CPI Card Group
PMTS
$286M
| $32.6K | ﹤0.01% |
1,828
-931
| -34% | -$17K |
2022 Q4
5 quarters
|
|
5855
Vuzix
VUZI
$252M
| $32.6K | ﹤0.01% |
26,972
-15,185
| -36% | -$24.8K |
2020 Q4
13 quarters
|
|
|
RENT
5856
Rent the Runway
RENT
$52.6M
| $32.6K | ﹤0.01% |
4,715
+1,264
| +37% | +$12K |
2021 Q4
9 quarters
|
|
5857
New England Realty Associates
NEN
$170M
| $32.4K | ﹤0.01% |
450
| – | – |
2019 Q3
18 quarters
|
|
5858
Franklin FTSE United Kingdom ETF
FLGB
$848M
| $32.3K | ﹤0.01% |
1,235
+836
| +210% | +$20.9K |
2023 Q1
4 quarters
|
|
|
VAXX
5859
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
| $32.2K | ﹤0.01% |
44,902
+17,048
| +61% | +$12.4K |
2023 Q1
4 quarters
|
|
|
BXMX
5860
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $32.1K | ﹤0.01% |
2,429
-5,045
| -68% | -$65.8K |
2023 Q2
3 quarters
|
|
5861
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.34B
| $32.1K | ﹤0.01% |
1,352
+682
| +102% | +$15.7K |
2023 Q3
2 quarters
|
|
5862
AirSculpt Technologies
AIRS
$138M
| $32.1K | ﹤0.01% |
5,224
-2,694
| -34% | -$18.3K |
2021 Q4
9 quarters
|
|
5863
Babcock & Wilcox
BW
$840M
| $32K | ﹤0.01% |
28,350
-281,576
| -91% | -$348K |
2020 Q2
15 quarters
|
|
5864
Noodles & Co
NDLS
$78M
| $31.9K | ﹤0.01% |
2,087
-1,174
| -36% | -$22.9K |
2016 Q4
29 quarters
|
|
5865
Invesco S&P 500 BuyWrite ETF
PBP
$391M
| $31.9K | ﹤0.01% |
1,418
-34
| -2% | -$749 |
2023 Q1
4 quarters
|
|
|
TEF
5866
DELISTED
Telefonica
TEF
| $31.8K | ﹤0.01% |
7,209
-58,741
| -89% | -$241K |
2013 Q2
43 quarters
|
|
5867
International General Insurance
IGIC
$1.05B
| $31.5K | ﹤0.01% |
+2,325
| New | +$30.3K |
2024 Q1
0 quarters
|
|
5868
Korea Electric Power
KEP
$14.3B
| $31.4K | ﹤0.01% |
3,768
+569
| +18% | +$4.6K |
2015 Q4
33 quarters
|
|
|
THQ
5869
abrdn Healthcare Opportunities Fund
THQ
$736M
| $31.2K | ﹤0.01% |
1,551
+300
| +24% | +$5.77K |
2023 Q3
2 quarters
|
|
|
NTRL
5870
First Trust Equity Market Neutral ETF
NTRL
$14.3M
| $31K | ﹤0.01% |
+1,566
| New | +$31.1K |
2024 Q1
0 quarters
|
|
|
TVRD
5871
Tvardi Therapeutics
TVRD
$15.2M
| $31K | ﹤0.01% |
946
+81
| +9% | +$2.1K |
2014 Q1
40 quarters
|
|
|
VSTE
5872
DELISTED
Vast Renewables
VSTE
| $30.9K | ﹤0.01% |
+10,000
| New | +$27.7K |
2024 Q1
0 quarters
|
|
|
LPSN
5873
DELISTED
LivePerson
LPSN
| $30.7K | ﹤0.01% |
2,052
-8,755
| -81% | -$301K |
2016 Q3
30 quarters
|
|
|
PNST
5874
DELISTED
Pinstripes Holdings, Inc.
PNST
| $30.7K | ﹤0.01% |
+9,445
| New | +$37.9K |
2024 Q1
0 quarters
|
|
5875
Beyond Air
XAIR
$2.8M
| $30.6K | ﹤0.01% |
44
-13
| -23% | -$8.93K |
2023 Q2
3 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.